All In MedTech

Device Trial Radar · NCT00069615

Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children

DirecNet Pilot Study to Evaluate the GlucoWatch G2 Biographer in the Management of Type 1 Diabetes in Children

Last checked: Nov 20, 2026Latest source record: Sep 5, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

15

Actual

Start

Feb 2003

Primary completion

Not stated

Study completion Jun 2003

Sponsor

Lead sponsor
Jaeb Center for Health ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Sep 30, 2003

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Who can join
All sexes, from 7 years, up to 17 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Devices such as the GlucoWatch G2 Biographer (GW2B), which constantly measure blood sugar levels, may improve the treatment of Type 1 diabetes mellitus in children. This study evaluated the GW2B when used by children in their homes.

Conditions

  • Diabetes Mellitus, Insulin-Dependent

Interventions

  • GlucoWatch® G2™ Biographer (GW2B)Device

  • Continuous Glucose Monitoring System™ (CGMS)Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Feasibility of using the GlucoWatch G2 Biographer
  2. Feasibility of collecting data from home computers

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Division of Pediatric Endocrinology and Diabetes, Stanford University

    Stanford, California

  • Barbara Davis Center for Childhood Diabetes, University of Colorado

    Denver, Colorado

  • Department of Pediatrics, Yale University School of Medicine

    New Haven, Connecticut

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.